Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06775821 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 15, 2025 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Study First Submitted
Retrospective clinical case studies in recent years have shown that most cases of lung cancer and abdominal aortic aneurysm (AAA) are detected at the same time and that there is a wide variation in the prevalence of AAA in patients with primary lung cancer reported in the literature, with some papers suggesting as high as 11%, suggesting that there may be a relationship between the prevalence of the two diseases. However, its exact incidence and mechanism are unknown. Accurate prevention of AAA in patients with primary lung cancer requires more in-depth studies. To solve the above problems, a multi-center prospective epidemiological investigation and mechanism study on the association of AAA in primary lung cancer combined has become particularly urgent. The results of the study will be of great significance for the follow-up treatment and prognosis of lung cancer patients as well as the improvement of long-term survival rate of lung cancer patients, and will also provide scientific basis and clinical guidance for the screening and prevention of AAA in lung cancer patients.
Trial Details
NCT Number NCT06775821
Lead Sponsor First Affiliated Hospital of Kunming Medical University
Collaborators: The Third Affiliated Hospital of Kunming Medical University, Kunming Medical University
Conditions
(from sponsor)
Abdominal Aortic Aneurysm, Primary Lung Cancer, Prevalence
Related terms Aortic Aneurysm, Abdominal
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov